The FDA has received 30,168 adverse event reports for cats that name Selamectin.
- 30,168 reports name Selamectin in cats, which is 20% of all 151,164 cat reports. A report counts under every active ingredient it names.
- 15% are marked serious and 4.9% record a death or euthanasia; across all cat reports those figures are 27% and 9.4%.
- 21% are complaints that the product did not work (19% across all cat reports).
- The clinical signs reported most are application site alopecia, application site hair loss and lack of efficacy (ectoparasite) - flea.
- The FDA lists 4 approved animal drug applications containing Selamectin for cats, the earliest approved in 1999.
- None of this is a rate. The FDA data does not record how many cats were given Selamectin, so it cannot say how often any of this happens.
How the reports break down
| What the reports say | Reports | Share of this medicine's reports | All cat reports |
|---|---|---|---|
| Marked seriousthe FDA record flags the report as serious | 4,437 | 15% | 27% |
| Death or euthanasiathe outcome recorded in the report, with no finding of cause | 1,486 | 4.9% | 9.4% |
| Did not worka complaint that the product failed to work, which the FDA files as an adverse event | 6,453 | 21% | 19% |
| Seizurea seizure or convulsion is among the clinical signs | 812 | 2.7% | 2.6% |
| Not used per labelthe report says the product was not used the way its label directs | 5,014 | 17% | 33% |
Where on the body do the reported signs sit?
Not on the body: Did not work 11% Whole body 9.8%
- Where it was applied47%application site alopecia, application site hair loss, application site scab, application site lesion and 5 more
- Stomach and gut19%vomiting, anorexia, diarrhoea, weight loss and 1 more
- Did not work11%lack of efficacy (ectoparasite) - flea, lack of efficacy (ectoparasite) - ear mite, ineffective, ascarids
- Whole body9.8%lethargy, death, fever
- Behaviour8.2%depression, behavioural disorder, hiding
- Brain and nerves2.5%ataxia
- Skin and coat2.2%pruritus
Each figure is a share of sign mentions among the 25 signs reported most for Selamectin in cats. One report can list several signs, so these do not add up to reports. The grouping into body systems is ours; the signs in each group are listed beside it.
Clinical signs reported most
- Application site alopecia5,967 20%
- Application site hair loss4,553 15%
- Lack of efficacy (ectoparasite) - flea2,928 9.7%
- Vomiting2,800 9.3%
- Anorexia2,183 7.2%
- Lethargy1,954 6.5%
- Depression1,688 5.6%
- Application site scab1,469 4.9%
Reports received per year
Is it approved for cats?
The FDA lists 4 approved animal drug applications containing Selamectin for cats, the earliest approved in 1999.
| Product | Form | Approved for | First approved | FDA application |
|---|---|---|---|---|
| RevolutionZoetis Inc. | Liquid RX | Cat, Dog | 1999 | 141-152 |
| Revolution PlusZoetis Inc. | Topical Solution RX | Cat | 2018 | 141-502 |
| SelaspotBimeda Animal Health Ltd. | Topical Solution RX | Cat, Dog | 2020 | 200-696 |
| SelamectinZyVet Animal Health, Inc. | Topical Solution RX | Cat, Dog | 2024 | 200-769 |
From the FDA record for Revolution: Federal law restricts this drug to use by or on the order of a licensed veterinarian. Do not use in sick, debilitated, or underweight animals.
What can you do next?
Report counts: FDA Center for Veterinary Medicine adverse event reports, read 11 November 2026 (FDA data last updated 5 October 2026). Approvals: Animal Drugs @ FDA, read 11 November 2026. Counts are reports, not animals and not doses.
Where can you go from this result?
This result is one of 94 in the lookup. See Selamectin in dogs (29,523 reports). Open it in the lookup to set it beside another medicine, or read how the counts were collected.
- Fluralaner in cats13,791
- Praziquantel in cats12,556
- Spinosad in cats11,875
- Moxidectin in cats11,447
To report a suspected side effect in your own animal, follow how to report an animal drug side effect to the FDA. The FDA explains what a report can and cannot show in openFDA's guide to reading the results.
Compiled by Vincent Wesley Couey, PetMaxxing Research (ORCID 0009-0005-6869-308X). Sources: openFDA animal and veterinary adverse event interface; Animal Drugs @ FDA.